Eye Drop

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Analisa Arosemena, MD, of CorrectVision Laser Institute discusses Vevye for the treatment of dry eye disease.

Previous unsuccessful topical therapy does not affect outcomes in patients who undergo surgical macular hole repair, according to a study presented at the American Society of Retina Specialists annual meeting.

In this Healio Video Perspective from the World Ophthalmology Congress, John D. Sheppard, MD, MMSc, FACS, of Virginia Eye Consultants discusses Miebo’s efficacy for dry eye disease in various patient subgroups.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

Most of us are familiar with the different classes of eye drops.

Spencer Trask & Co. announced the launch of Signal12, a clinical-stage dry eye company that plans to advance Pro-ocular for the treatment of dry eye disease, according to a press release.

OcuSoft announced the launch of Retaine Allergy, a prescription-strength olopatadine hydrochloride ophthalmic solution 0.2% for eye allergy itch relief.

Multiuse eye drop bottles are often discarded at medical centers long before the FDA-regulated expiration date, leading to significant drug waste and increased costs, according to research published in Ophthalmology.

PARK CITY, Utah — Stage one of the phase 3 DIAMOND trial of OCS-01, a high-concentration dexamethasone eye drop for diabetic macular edema, showed promising safety and efficacy outcomes. Stage two of the trial is underway.

NASHVILLE, Tenn. — A lipid-containing eye drop not only was shown to be noninferior to non-lipid-containing drops but it also improved patients’ dry eye signs and symptoms, according to a study presented at Optometry’s Meeting.